Sévan Kaloustian has been elected as Vice-President of the Romanian Affiliation of Worldwide Medicines Producers (ARPIM) for a 2-year mandate, on the group’s most up-to-date General Meeting.
By way of this new project, the Managing Director of Janssen pharmaceutical firms of Johnson & Johnson in Romania will take additional steps to strenghtening the corporate’s mission on the native panorama, via collaboration and open dialog with the well being authorities and stakeholders. Mr. Kaloustian’s latest new position within the ARPIM will enable him to place his intensive worldwide background in the good thing about the Romanian sufferers.

With over 10 years of expertise within the pharmaceutical business, Sévan Kaloustian performed a key position inside the Janssen firm, throughout the years in numerous features, in facilitating sufferers entry to the corporate’s revolutionary medicines portfolio. He holds a Ph.D. in Pharmacology and a Grasp in pharmaco-economy, each from College of Montreal, Canada, and a Ph.D. fellowship at Academia Sinica in Taiwan and a digitalization specialisation at Columbia Enterprise College, New York.
“The election as ARPIM’s Vice-President honours me and reinforce our efforts towards our frequent objective, to contribute to constructing a more healthy future for Romania. Johnson & Johnson Romania has a long-standing dedication to authorities, society, and sufferers. Our mission is evident and our path is settled: we’ll be working collectively to proceed rising the sufferers’ entry to revolutionary medicines, advancing our joint effort across the clawback tax, the pricing model, the predictability of the reimbursement listing and shaping a extra beneficial laws for scientific trials. Particularly in these moments, it’s essential to make all the pieces in our powers to assist align the Romanian’s sufferers’ wants and rights on the European degree, to ensure they good thing about the perfect well being levers out there.”, stated Sévan Kaloustian, Managing Director Janssen pharmaceutical firms of Johnson & Johnson Romania.